Our Global Life Sciences team draws on its industry expertise to help companies as they grow into new international markets. We work with fast growing companies and the largest multinationals to drive growth and manage risks.
The life sciences industry is facing a perfect storm of converging issues. The 'patent cliff' and increasing demands of transforming scientific research and discoveries into marketable products have intensified the need to identify viable opportunities quickly.
Sourcing funds for R&D, pre-clinical and early-phase drug development, and necessary investment in evolving technologies is particularly difficult considering efforts to reduce the cost of healthcare and related impacts on profits. Many life science companies have evaluated mergers, acquisitions or strategic alliances as options to address these opportunities and challenges. Others are looking to expand overseas into new markets.
Most of these transactions are complex, multi-faceted, and create significant uncertainty regarding financial reporting. Businesses dealing with these issues require advisors with experience and insight into these arrangements and the many challenges that come with them.
From understanding the complexities of research and development tax credits and regulations, to licensing agreements and due diligence, our international Life Sciences team provides guidance to pharmaceutical, biotech, and medical device manufacturers at every stage of their lifecycle.
We advise clients on how best to access capital, which is crucial to fuelling innovation, research, and development efforts. From a tax perspective, BDO identifies significant opportunities to drive value, and assists businesses in structuring their operations in the most tax-efficient manner possible.
We draw on our industry expertise and local market knowledge in 154 countries and territories to help you minimise the risks of international expansion and maximise the opportunities.